• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

Poster Sessions at the SPD 2022 47th Annual Meeting

An extraordinary display of posters at this year's Society for Pediatric Dermatology annual conference.

A large and impressive roster of poster sessions covering a broad range of pediatric dermatologic conditions is available this year at the SPD 2022 47th Annual Meeting. Poster sessions cover a landscape of current pediatric dermatology trials, which include new therapeutic agents for pediatric atopic dermatitis and psoriasis, some of which have, until now, only been available in adult populations.

Elswhere, a fascinating look at diaper dermatitis, the most common disorder among infants: the best prevention is frequent diaper change, but in Lytle, Texas, where 1 in 3 families fall below the poverty line, many are unable to afford diapers. This study evaluated the financial monthly impact for each family, and how the Bridging the Diaper Gap program (which offers affordable diapers to families in need) can help. Results showed, through the program, impressive improvements in infant dermatitis conditions. Pre-surveys indicated 36% of participants reported babies having dermatitis once within the past year; post-surveys noted no dermatitis cases after using the program. With the help of this program, families saved nearly $70 over 3 months in purchasing diapers, and this program will soon be expanded to other parts of Texas.

Although coconut is a rare allergy, patients with atopic dermatitis (AD) may be at risk for sensitization. Coconut oil is commonly used by patients with AD; this study aimed to look at coconut sensitization and allergy in pediatric patients as the use of coconut-containing products increases. This medical record review of pediatric patients aged 0 to 17 years with sensitivy to coconut were used to assess prior skin prick testing, personal and family medical histories. The study showed 47% of patients reporting reactions to coconut, with cutaneous reactions including urticaria and localized eczema flares, italicizing the fact that dermatologists should be noting what coconut products their patients who present with AD might be using.

Psychosocial issues from traumas such as burns are also front and center in pediatric dermatology studies, with a poster investigating the impact and burden of generalized anxiety disorder (GAD) among hospitalized pediatric burn patients. Although previously, major depression and PTSD have been investigated in past reports, studies on the presentation of patients with GAD in this population remain scarce. Here, investigators sought to characterize patients with GAD following pediatric burns, to assess their length of stay and total charges in hospitals, compared to pediatric burn patients without GAD. Investigators used the 2016 Kids' Inpatient Database (KID) to look at cases of pediatric burns. Demographic statistics, common comorbidtities, and associated costs were collected and compared between patients with and without GAD. Results showed that of 8494 cases of pediatric burns, (4.6% had GAD, 95.4% did not), patients with GAD were older (13 years v 7 years); a greater proportion (51.4%) were female and White (62.4%). Results showed that although those burn victims with GAD were a small percentge, those with GAD were older, female, of higher income status and on private insurance. As a result, although GAD patients stay in the hospital longer thn non-GAD patients (receiving more procedures) their total charges were not significantly different. This study might help dermatologists in considering recommending longer stays at hospitals for their GAD patients to get the additional services they need to improve mental health outcomes.

References

Martin C, Nambudiri VE. A landscape of current pediatric dermatology clinical trials: what does the future therapeutic pipeline hold? SPD 2022 47th Annual Meeting. Poster presentation. July 7-10, 2022. Indianapolis, Indiana.

Chakales A, England M, Collins M, Kohler K, Johnson B. Bridging the diaper gap. SPD 2022 47th Annual Meeting. Poster presentation. July 7-10, 2022. Indianapolis, Indiana.

Yousif R, Fishbein AB, Kruse L. Coconut allergy and its relationship to facial atopic dermatitis. SPD 2022 47th Annual Meeting. Poster presentation. July 7-10, 2022. Indianapolis, Indiana.

Desai AD, Kumar KD, Shah VP, Patel AM, Lipner SR. Investigating the impact and burden of generalized anxiety disorder among in-patient pediatric burn patients. SPD 2022 47th Annual Meeting. Poster presentation. July 7-10, 2022. Indianapolis, Indiana.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.